Abstract. Intracellular filamentous inclusions containing abnormally phosphorylated tau protein are hallmarks of several human neurodegenerative disorders. This study reveals tau-positive cytoskeletal abnormalities in neurons and glial cells of aged baboons. The brains of four baboons (Papio hamadryas, 20-30 yr of age) were examined using the Gallyas silver technique for neurofibrillary changes and phosphorylation-dependent anti-tau antibodies (AT8, AT100, AT270, PHF-1, TG-3). Conspicuous changes were noted in two animals, 26 and 30 yr of age. In both animals, a combination of neuronal and glial cytoskeletal pathology was seen preferentially affecting limbic brain areas, including the hippocampal formation. In the 30-yr-old animal, numerous tau-positive inclusions were seen in the granule cells of the fascia dentata. These cells even exhibited an accumulation of argyrophilic neurofibrillary tangles. The glial changes affected both astrocytes and oligodendrocytes. Tau-positive astrocytes were seen in perivascular, subpial, and subependymal locations. Tau-positive oligodendrocytes preferentially occurred in limbic fiber tracts including the entorhinal perforant path. Ultrastructurally, tau-positive straight filaments (10-14 nm) in both neurons and glial cells were revealed by anti-tau immunoelectron microscopy. This study thus indicates the potential usefulness of aged baboons for experimental investigation of neuronal and glial filamentous tau pathology. This nonhuman primate species may provide valuable information pertinent to the broad spectrum of human tauopathies.
INTRODUCTION
Cytoskeletal changes associated with abnormally phosphorylated tau proteins are key features of several human neurodegenerative disorders. In Alzheimer disease (AD) tau-positive filamentous inclusions are found in the cell bodies (neurofibrillary tangles; NFTs) and in processes of specific subsets of vulnerable neurons (1, 2) . Such altered neurons eventually perish for reasons that are not yet known. Filamentous tau pathology is not unique to AD but is also seen in other ''tauopathies,'' including corticobasal degeneration (CBD; [3] ), Pick's disease (PID; [4, 5] ), progressive supranuclear palsy (PSP; [6] ), and argyrophilic grain disease (7, 8) . These diseases are distinct from AD in that different brain areas are affected and abundant tau-positive inclusions in glial cells are present (9) (10) (11) . Interestingly, neuronal and glial tau pathology also occurs in hereditary tauopathies referred to as frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17; [12, 13] ). FTDP-17 is caused by dominant mutations in the tau gene (14) which impair major biochemical properties of the tau proteins (15) .
This genetic link underlines the significance of tau dysfunction as a pathogenic factor causative of human neurodegeneration and dementia.
The cellular mechanisms that underlie the abnormal phosphorylation and filamentous aggregation of tau are poorly understood. Unfortunately, a suitable in vivo model of filamentous tau pathology is unavailable. Only a few animal species are prone to spontaneous deposition of abnormal tau (16) (17) (18) (19) (20) . The brains of aged nonhuman primates, in particular, are considered to be virtually resistant to tau pathology (21) (22) (23) (24) . Here we report the existence of surprisingly pronounced tau pathology in brains of aged monkeys. These changes were identified in baboons (Papio hamadryas) and affected not only neurons but also astrocytes and oligodendrocytes.
MATERIALS AND METHODS
The brains of four aged baboons (Papio hamadryas) were examined. The animals had been raised and housed in zoological gardens in Germany. The estimated ages and genders of the animals were: 20 yr (female); 24 yr (female); 26 yr (male); and 30 yr (male), with a mean age of 25 yr. Ages were determined by history, dentition, and general appearance at the time of acquisition. All animals died of natural causes or were euthanized because of terminal illness. No experimental studies or behavioral testing had been performed on any of the animals prior to death. The social ranking of the animals was unknown. Autopsies were performed by the departments of veterinary pathology in Frankfurt/Main (Germany) and Munich (Germany).
All four brains had been immersion-fixed in a 4% aqueous solution of formaldehyde. No fresh unfixed tissue was available. Following midsagittal sectioning of the brain, one hemisphere of each animal was cut into tissue blocks of 0.5-1 cm thickness perpendicular to the intercommissural axis. Tissue blocks were embedded in polyethylene glycol (PEG 1000; [25] ) → Fig. 1 . Cytoskeletal abnormalities in a 30-yr-old male baboon detected by AT8 immunostaining (a-f) and Gallyas silver staining (g-j). (a) Frontal hemisphere section cut at the level of the corpus mamillare (CM). A dense accumulation of AT8-positive cytoskeletal changes is seen in the hippocampal formation (hf). (b) Distribution of cytoskeletal changes within the hippocampal formation. A moderate density of AT8-positive inclusions is seen in the first and third sector of the Ammon's horn (CA1 and CA3). Cytoskeletal changes are even more pronounced in CA4, whereas CA2 is almost devoid of changes. The highest density of changes is seen in the fascia dentata (FD; arrow). Arrowheads point to subpial astroglial cytoskeletal changes bordering the hippocampal fissure (see Fig. 4 ). (c) Layer-specific pathology in the fascia dentata. AT8-positive inclusions in the outer molecular layer resemble oligodendroglial coiled bodies (see Fig. 5 ). The inner molecular layer (IML) and the subgranular plexiform layer (PL) of the fascia dentata contain altered neuropil structures. Note the dense accumulation of altered neurons in the granule cell layer (GCL), which is particularly pronounced in the deeper granule cell layers (arrowheads). (d) Cytoskeletal changes of the fascia dentata at higher magnification. The granule cell layer (GCL) contains numerous cellular inclusions bordered by the neuropil changes of the inner molecular layer (IML) and the plexiform layer (PL). (e) Moderate degree of cytoskeletal changes in medial portion of the uncus. Intracellular inclusions occur predominantly in the granule cell layer (GCL). Open arrow points to an altered granule cell, which is also denoted by an open arrow at the higher magnification shown in (f). Framed box denotes a subpial accumulation of astroglial changes shown at higher magnification in Figure 4d and cut into uninterrupted series of alternating 50-and 100-m-thick frontal sections. As positive control tissue, hippocampal sections of a human AD case were processed simultaneously for cytoskeletal abnormalities using the techniques described below.
Staining was performed on free-floating sections. Aldehydefuchsin plus Darrow red staining for lipofuscin pigment and Nissl material provided topographical orientation (26) . The modified Gallyas silver iodide method was utilized to demonstrate argyrophilic tau-positive pathology in neurons and glial cells (25, 27) . Amyloid deposits were stained using the Campbell-Switzer silver pyridine method (25) . In addition, the monoclonal antibody 4G8 directed against the amyloid ␤-protein (A␤ 17-23; 1:5000, Senetek, Maryland Heights, MO) was used for immunostaining of A␤ deposits.
Abnormally phosphorylated tau protein was detected using a panel of monoclonal phosphorylation-dependent antibodies including AT8, AT100, AT270 (28) (29) (30) (31) [each 1:1000, Innogenetics, Ghent, Belgium], PHF-1 (32) [1:250] , the monoclonal antibody TG-3 [1:10] , and the phosphorylation-independent monoclonal anti-tau antibody Alz-50 (34, 35) [1:20] . The PHF-1, TG-3, and Alz-50 antibodies were gifts of Dr. P. Davies, Albert Einstein College of Medicine, New York. The tau phosphoepitopes detected by AT8, AT270, AT100, and PHF-1 have all been identified in AD-related tau pathology (28, 30, 32, 41) and in other human tauopathies. The TG3 antibody recognizes conformation-sensitive and phosphorylation-dependent epitopes on abnormal tau (33) . A rabbit polyclonal antibody (anti-GFAP, 1:500, Dako, Glostrup, Denmark) was used to label glial fibrillary acidic protein.
For single immunostaining, incubation with the primary antibodies was performed for 40 to 44 h at 4ЊC followed by incubation with biotinylated secondary antibodies for 2 h at room temperature. Bound antigens were visualized with the ABCcomplex (Vectastain, Vector Laboratories, Burlingame, CA) and 3, 3Ј-diaminobenzidine-tetra-HCl/H 2 O 2 (DAB, D5637 Sigma).
For double immunofluorescence staining, sections were incubated with AT8 (1:1000, 24 h, 20ЊC), then reacted with carbocyanine (Cy2)-incorporated anti-mouse immunoglobulins (1: 100, 4 h, 20ЊC, Dianova, Hamburg, Germany). Subsequently, sections were incubated with anti-GFAP (1:500, 24 h, 20ЊC) and anti-rabbit IgG coupled to indocarbocyanine (Cy3, 1:100, 4 h, 20ЊC, Dianova, Hamburg, Germany). Double immunostained sections were examined using a LSM 510 confocal microscope (Zeiss, Germany) with a krypton/argon and helium/ neon laser. For Cy2, the excitation filter was 488 nm and the emission filter was 505-530 nm. For Cy3, the excitation and emission filters were 543 and 560-615 nm respectively.
Hippocampal sections of the 30-yr-old animal were immunostained with the polyclonal anti-tau antibody 92e (1:5000, anti-rabbit; [36, 37] ) using a secondary antibody linked to colloidal gold (Aurion GAM IgG/M GP-US, 5 nm, 1:1000, 5 h). 92e labels NFTs on tissue sections and NFT-associated paired helical filaments (PHF) on immunoblots but does not crossreact with normal constituents of the cytoskeleton including microtubules and neurofilament polypeptides (36) . Sections were postfixed in glutaraldehyde and OsO 4 , silver enhanced (Aurion), dehydrated, and embedded in Araldite. Semithin sections were stained with methylene blue. Ultrathin sections were placed on FORMVAR-coated 1 hole copper grids, counterstained with 1% lead citrate and saturated uranylacetate, and examined using a Zeiss EM 109 electron microscope.
RESULTS
At gross examination the brains of the baboons did not exhibit obvious atrophic changes, identifiable ischemic lesions, or apparent tumors. Microscopically, the brains of the two younger baboons, age 20 yr and 25 yr, were almost devoid of cytoskeletal abnormalities except for single tau-positive inclusions. In contrast, the brains of the remaining two older animals, age 26 yr and 30 yr, exhibited pronounced changes visible even to the naked eye (Fig. 1a) . In both animals the changes were most prominent in medial temporal lobe structures including the hippocampal formation (Figs. 1, 2a) and the nuclear complex of the amygdala (Fig. 2b) . The changes in these regions were highlighted by the general scarcity of taupathology in neocortical regions, the basal ganglia, thalamus, and subthalamic region. The changes in both affected animals were not restricted to nerve cells but also consisted of astroglial and oligodendroglial inclusions. Both neuronal and glial changes were labeled by all the anti-tau antibodies employed in this study. A fraction of the neuronal and glial inclusions (approximately 10%) was demonstrated using the Gallyas silver staining technique.
Neuronal Changes
Abnormal tau protein was deposited in somata and processes of nerve cells. The immunoreactive inclusions frequently consisted of diffusely distributed granular material labeling even distal dendritic segments (Fig. 2a, b ). This Golgi-like staining pattern facilitated morphological classification of affected cell types. The vast majority of the affected nerve cells apparently belonged to the class of projection neurons.
Both affected animals exhibited abnormal tau-positive inclusions in projection neurons of the amygdala (Fig.  2b ) and in pyramidal neurons of the hippocampus proper, which were located mainly in the first and third Ammon's horn sector (Fig. 2a, CA1 and CA3). A differential vulnerability was noted in the dentate gyrus. In the 26-yrold animal, this particular region was afflicted only to a mild degree. As detailed below, a striking lamina-specific pathology was noted in the dentate gyrus of the 30-yrold animal (Fig. 1 ). The granule cell layer of this animal accumulated significant numbers of densely aggregated tau-positive inclusions distributed in a layer-dependent manner. The highest density of changes was seen in the deeper granule cell layers, followed by the superficial granule cells located subjacent to the inner molecular layer ( Fig. 1b-d ). In comparison, intermediate cell layers tended to be less severely involved. Dense neuropil changes, immunopositive for abnormal tau, were seen in the plexiform layer of the hilus and the inner third of the molecular layer (Fig. 1b-d) , whereas the outer two thirds of the molecular layer remained largely unaffected by such changes. The neuropil changes consisted of immunoreactive terminal-like punctae and clusters of small immunoreactive neurites. Abnormal tau was also detected in axon-like fibers following the predicted course of the mossy fibers to the stratum lucidum of CA3.
Proceeding medially towards the uncus, the changes of the fascia dentata decreased in density (Fig. 1e, f) . In this region abnormal tau in individual granule cells was less densely aggregated and diffusely distributed labelling even distal spiny dendrites. Mild neuropil changes of the inner molecular layer and plexiform layer were noted, mainly in proximity to processes of immunoreactive granule cells (Fig. 1e, f) .
The vulnerability of the granule cell layer was confirmed using the Gallyas technique. A substantial number of argyrophilic NFTs was seen in the granule cells (Fig.  1g, h) , preferentially affecting deeper cell layers. These NFTs consisted of crescent-shaped spherical accumulations of fibrillary material deposited around the cell nucleus (Fig. 1i) . Occasionally, Gallyas-positive filamentous NFTs were also detected in large neurons in the hilus of the 30-yr-old animal (Fig. 1j) and in pyramidal neurons of CA1. In the 26-yr-old animal only isolated argyrophilic NFTs, chiefly located in CA1, were labelled.
Astroglial Changes
The astrocytic nature of tau-positive inclusions was strongly suggested by the characteristic morphology and distribution of inclusions localized in stellate cell bodies, giving rise to numerous radiating processes (Fig. 3) . Some of these processes terminated with multiple end feet abutting walls of blood vessels (Fig. 3a-c) . Other astroglial inclusions were characterized by a deposition of aggregated abnormal tau in the periphery of the perikarya, extending into proximal thorn-shaped processes ( Fig. 3d-i) . Such inclusions were distributed preferentially in perivascular, subependymal, and subpial locations of limbic brain areas such as the hippocampal formation (Fig. 1b, e) , and the periamygdaloid cortex. Astroglial involvement was confirmed by confocal microscopic analysis of sections double-stained with anti-GFAP and AT8. Abnormal tau protein was detected in both cell bodies and processes of GFAP-positive astrocytes (Fig. 4) . Although located in the same cellular structures, the tau-positive material and the GFAP-immunoreactivity often occupied spatially distinct domains. Some inclusions, considered to be astrocytic in nature due to their typical morphology and distribution, exhibited only weak or even absent GFAP-immunoreactivity. Astroglial changes were also identified in circumscribed segments of the glial limiting membrane consisting of a dense network of tau-positive processes (Fig. 3d) . These changes were often located in the vicinity of clusters of subpial tau-positive astrocytes. The changes of the glial limiting membrane were prominent in the subpial zone of the hippocampal sulcus extending laterally toward the obliterated hippocampal fissure (Fig. 1b) . Similar changes were found along the basolateral surface of the tuber cinereum. Although reduced in density, the distribution of Gallyas-positive astroglial changes closely resembled that demonstrated by immunostaining for abnormal tau. 
Oligodendroglial Changes
Additional distinctive glial inclusions consisted of small cellular inclusions that were particularly conspicuous in myelinated fiber tracts of the limbic system (Fig.  5) . They occurred as coil-shaped somatic deposits of abnormal tau extending into proximal portions of branching cellular processes (Fig. 5c-j) . These inclusions were frequently twisted around a relatively large unstained center occupied by a nucleus closely resembling that of oligodendroglia (Fig. 5j) . Morphologically, the coiled inclusions were indistinguishable from oligodendroglial inclusions in the human brain referred to as coiled bodies (38, 39) . A portion of the coiled bodies in the baboons was also rendered visible by the modified Gallyas technique (Fig. 5i,  j) . Coiled bodies were accompanied by interfascicular threadlike fibers containing abnormal tau protein. In both the 30-yr-old and the 25-yr-old baboon, the most extensive accumulation of coiled bodies and interfascicular fibers was seen throughout the entire course of the entorhinal perforant path (Fig. 5b) , including its termination zone in the outer molecular layer of the fascia dentata (Fig. 1c) . Similar changes were seen in the alveus (Fig. 1c) and fimbria of the hippocampus, as well as in the descending column of the fornix situated in the hypothalamic tuber cinereum (Fig. 5a ). The mild amyloid deposits of the 30-yr-old animal were confined to lateral portions of the superior temporal gyrus (framed box denoted by A). The ␤-amyloid deposits in the 25-yr-old animal mainly were distributed in the inferior temporal neocortex (framed box denoted by B, C). Note that in both animals the medial temporal lobe (mtl) including the hippocampal formation (hf) and the parahippocampal gyrus (ph) remained devoid of ␤-amyloid deposition.
␤-Amyloid Deposition
Both the antibody 4G8 and the Campbell-Switzer silver staining technique demonstrated a mild to moderate degree of ␤-amyloid deposition in the baboons. A␤ was found in plaque-like deposits not associated with blood vessels (Fig. 6a, b) , as well as in the walls of blood vessels affected by cerebral amyloid angiopathy (Fig. 6c) . Lesions resembling neuritic plaques were not observed. ␤-amyloid deposits were mainly found in neocortical regions such as the inferior and superior temporal cortices (Fig. 6d) . The severity and the distribution of the ␤-amyloid deposits appeared to be unrelated to that of taupositive cytoskeletal abnormalities. In the 30-yr-old animal, for example, only a few amyloid deposits were identified and were chiefly localized in the superior temporal gyrus (Fig. 6a, d) , although the hippocampal formation of this animal remained unscathed by A␤ deposition. In the 26-yr-old animal, A␤ pathology was more pronounced and mainly localized in the inferior temporal neocortex (Fig. 6b-d) . The medial temporal lobe of this animal, including the hippocampus and amygdala, was virtually devoid of A␤ pathology. The remaining two younger animals exhibited zero or very few neocortical amyloid deposits. 
Electron Microscopy
Ultrastructural analysis of anti-92e immunostained ultrathin sections of the fascia dentata of the 30-yr-old animal revealed single filamentous profiles or bundles of filaments immunolabelled by 92e (Fig. 7) . Such abnormal tau-positive filaments were identified in granule cells (Fig. 7a, b) , in oligodendroglial coiled bodies located in the outer molecular layer (Fig. 7c, d) , as well as in processes of the glial limiting membrane (Fig. 7e) . The latter were classified to be astrocytic in nature by the coexistence of bundles of 8-to 10-nm-thick filaments closely resembling astroglial fibrils. In both neurons and glial cells the abnormal 92e-positive filaments measured 10 to 14 nm (mean 12 nm) in diameter. Although these filaments occasionally had a beaded, irregular appearance suggestive of constrictions, they did not demonstrate a distinct helical periodicity reminiscent of paired helical filaments (PHF).
DISCUSSION
This study demonstrates the existence of filamentous cytoskeletal changes associated with abnormally phosphorylated tau protein in the brains of two aged baboons (Papio hamadryas). Several lines of evidence indicate that the intracellular inclusions identified in these animals represent pathological changes. In particular, abnormal tau-positive filamentous inclusions were demonstrated in dentate gyrus granule cells and glial cells using anti-tau immunoelectron microscopy. This finding indicates that the aged baboon permits experimental investigation not only of abnormal tau phosphorylation but also of the intracellular assembly of this protein into insoluble filamentous aggregates. The latter process of tau assembly is considered a crucial step in the pathogenesis of human tauopathies (2, 40) .
The inclusions in the baboons were labeled by monoclonal tau antibodies recognizing abnormally phosphorylated epitopes along the length of the tau molecule. The abnormal tau protein in the baboons was distributed throughout the somatodendritic domain of susceptible neurons. This pattern contrasts with the predominantly axonal localization of tau in the normal adult brain (42) . The altered neurons of the baboons thus not only exhibit an abnormal phosphorylation of tau but also an aberrant compartmentalization of this protein. A similar somatodendritic accumulation of abnormal tau is a feature common to all human tauopathies (43) . In AD, for example, diffusely distributed abnormal tau is seen in cell bodies and dendrites of specific subsets of vulnerable nerve cells (1, 44) . This phenomenon is considered an early degenerative change preceding the formation of argyrophilic NFTs (1) . Likewise, the tau-positive neurons in the baboons appear to be at higher risk of developing NFTs. This is strongly suggested by the predilection of Gallyaspositive NFTs in regions containing the highest density of abnormal tau-positive inclusions, such as the fascia dentata of the 30-yr-old animal.
The cytoskeletal pathology in the baboons is remarkable in that it contradicts the widely accepted notion that aged nonhuman primates are generally resistant to formation of abnormal tau. Indeed, previous studies on great apes including chimpanzees (Pan troglodytes; 22) and orangutans (Pongo pygmaeus; 45) have failed to reveal tau-associated cytoskeletal changes. Several studies have investigated the rhesus monkey for Alzheimer-like neurofibrillary changes (22) (23) (24) (46) (47) (48) (49) . In an early study, aggregates of abnormal fibrillar material were rarely seen within cortical dendritic processes of two rhesus monkeys (46) . The significance of this finding for the formation of tau-associated pathology remained undetermined since specific anti-tau-antibodies were unavailable at that time. With the exception of only one report published in abstract form (49) , the subsequent investigations did not detect any neurofibrillary changes in rhesus monkeys. In the absence of confounding Alzheimer-like neurofibrillary degeneration, the rhesus monkey is considered a useful model for normal human brain aging (for review: 21). In contrast, 2 of 4 aged baboons in the present study exhibited pronounced tau-positive changes visible even to the naked eye. This raises the question whether the baboon, for reasons still undetermined, represents a nonhuman primate species exceptionally vulnerable to the formation of abnormal tau. A larger sample of aged baboons and further comparative studies including other species are needed to resolve this issue.
Sporadic formation of tau-positive argyrophilic inclusions was previously identified in few nonprimate species such as sheep (Ovies aries; 18, 19) , goats (Capra hircus; 17), an Asiatic brown bear (Ursus arctos; 16), and an aged wolverine (Gulo gulo; 20) . The cytoskeletal changes in these species were limited to neuronal involvement. The baboons, however, exhibited additional glial tau pathology. This finding is interesting in view of the extensive glial tau pathology seen in most of the non-Alzheimer-related tauopathies, for example, in PSP, PID, CBD, (9, 10, 40) . In addition, the occurrence of glial tau pathology provides an important similarity between the present study and the findings described in some of the FTDP-17 pedigrees (50, 51) . The significance of glial inclusions for the histopathological differential diagnosis of human tauopathies has been firmly established (9) (10) (11) 52) . In contrast, very little is known on the pathogenesis and clinical significance of glial tau inclusions. Further studies are required to determine whether aged baboons may serve as an in vivo model of glial tau pathology to explore these issues further.
Several previous experimental studies have succeeded in inducing abnormal tau in vivo. Microinjections of insoluble amyloid ␤ protein in the aged rhesus cerebral cortex result in focal accumulations of intraneuronal abnormally phosphorylated tau protein (53) . Focal accumulations of abnormal tau, localized in cellular processes of undetermined origin, were also observed in mice expressing the human ␤-amyloid precursor protein with AD-associated mutations (54) . In two transgenic mouse models a somatodendritic localization of hyperphosphorylated tau was induced by expression of wild-type human tau (55, 56) . Unfortunately, all of these models are limited since they fail to replicate the entire sequence of neurofibrillary degeneration leading to cell loss in the human brain (43) . In particular, filamentous inclusions in the form of argyrophilic NFTs were not observed in any of the above-mentioned models. Another inherent limitation of the transgenic approach is the low level of phylogenetic homology between the murine brain and that of humans. Based on the present description of filamentous tau pathology in baboons, these animals may be a suitable species for circumventing these limitations.
A nonrandom lesional distribution pattern is a key feature of all human tauopathies. The phenomenon of selective vulnerability to abnormal tau can also be studied in the baboon. Specific cell types in the medial temporal lobe of these animals were preferentially affected, whereas others were spared. To date, a complete homology between the changes in the baboon and a single human tauopathy cannot be established. The surprisingly pronounced affection of the dentate gyrus granule cells identified in the 30-yr-old animal deviates from the pattern observed in the hippocampus of human AD brains. Indeed, the human granule cells are relatively resistant to AD-related neurofibrillary changes, developing NFTs only in the endstage of the disease (57) . Moreover, the extensive accumulation of glial inclusions, as found in both affected animals, is not characteristic of AD (11, 40) . Instead, the granule cell changes and the glial inclusions point to non-Alzheimer-related tauopathies such as argyrophilic grain disease (AGD; for review : 7, 8) . AGD is characterized by deposition of abnormal tau in specific limbic neurons and macroglial cells. (7, 58, 59) . Based on histopathological and genetic findings (7, 58, 60, 61) , AGD is considered a distinct entity. The distribution of coiled bodies in the baboons resembled that previously reported for human AGD cases. A preferential accumulation of oligodendroglial inclusions in the perforant pathway, hippocampal alveus, mammillothalamic tract, and fornix has indeed been recently described in AGD (7, 60) . The question whether the aged baboon may serve as a model for AGD needs to be addressed in future studies that include a larger number of animals. With reference to the distribution of the astroglial inclusions of the baboons, it should be noted that certain basal areas of the aged human brain also demonstrate abnormal tau in subpial and perivascular astrocytes (62) . The significance of these human astroglial changes still must be determined.
Deposition of ␤-amyloid occurs in many different species of aged nonhuman primates (24, 63, 64; for review: 21). Likewise, we were able to detect diffuse plaque-like A␤ deposits and vascular amyloid in the baboon. Accordingly, this species permits examination not only of filamentous tau pathology but also of A␤ deposition. This combination is noteworthy since these two types of lesions are the histopathological key features of AD. The relationship between extracellular A␤ deposits and intracellular cytoskeletal pathology is an important, albeit controversial, issue in AD research. (65, 66) . In the present study no obvious relationship between ␤-amyloid deposits and tau-associated cytoskeletal changes was detected in the baboon. A␤ deposits were chiefly found in neocortical areas that were devoid of cytoskeletal changes. In contrast, tau pathology was prominent in the hippocampal formation, which remained virtually unaffected by amyloid deposition. The latter observation is consistent with previous reports demonstrating the presence of very few, if any, plaques in the hippocampus of various species of aged nonhuman primates (47, 64, 67) . In the baboon, the different distribution patterns of ␤-amyloid deposits and tau pathology may indicate that these changes develop independently of each other. Interestingly, tau pathology developing independently of A␤ is a well-recognized feature of non-Alzheimer-related tauopathies in the human brain (13) .
In summary, this study has two major implications. First, it extends the range of pathological changes that can be studied in both the human and nonhuman brain. The aged baboon demonstrates many of the pathological alterations that have been reported in human tauopathies. As in the human brain, filamentous tau pathology in the baboon is not restricted to neurons, but affects neuroectodermal glial cells as well. Second, it should be taken into account that tau pathology in animals may not necessarily be pertinent to AD-like pathogenetic mechanisms alone. Instead, further investigation of aged baboons may also provide information critical to our understanding of the broad spectrum of non-Alzheimer-related human tauopathies.
